{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:44:33Z","timestamp":1785793473436,"version":"3.56.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.lungcan.2024.107996","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T01:38:00Z","timestamp":1729733880000},"page":"107996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Treatment with trimetazidine dihydrochloride and lung cancer survival: Implications on metabolic re-programming"],"prefix":"10.1016","volume":"197","author":[{"given":"Yap-Hang","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Yuen-Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6612-0561","authenticated-orcid":false,"given":"Chun-Fung","family":"Sin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond S.K.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.S.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiu-Lun","family":"Au Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard M.Y.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4499-5284","authenticated-orcid":false,"given":"Chung-Man","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Hang","family":"Yiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Fat","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lungcan.2024.107996_b0005","first-page":"e62953","article-title":"The interplay between cardiovascular disease and lung cancer","volume":"16","author":"Katic","year":"2024","journal-title":"Cureus"},{"issue":"10299","key":"10.1016\/j.lungcan.2024.107996_b0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lungcan.2024.107996_b0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.lungcan.2024.107996_b0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2016.07.003","article-title":"Acidosis drives the reprogramming of fatty acid metabolism in cancer cells through changes in mitochondrial and histone acetylation","volume":"24","author":"Corbet","year":"2016","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107996_b0025","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41590-023-01430-3","article-title":"CD40 signal rewires fatty acid and glutamine metabolism for stimulating macrophage anti-tumorigenic functions","volume":"24","author":"Liu","year":"2023","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107996_b0030","doi-asserted-by":"crossref","DOI":"10.1172\/JCI133081","article-title":"Targeting the mitochondrial trifunctional protein restrains tumor growth in oxidative lung carcinomas","volume":"131","author":"Amoedo","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"32","key":"10.1016\/j.lungcan.2024.107996_b0035","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1093\/eurheartj\/ehab325","article-title":"Statin associated lower cancer risk and related mortality in patients with heart failure","volume":"42","author":"Ren","year":"2021","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107996_b0040","doi-asserted-by":"crossref","first-page":"e1003880","DOI":"10.1371\/journal.pmed.1003880","article-title":"Low-dose aspirin and incidence of lung carcinoma in patients with chronic obstructive pulmonary disease in Hong Kong: a cohort study","volume":"19","author":"Yu","year":"2022","journal-title":"PLoS Med."},{"key":"10.1016\/j.lungcan.2024.107996_b0045","article-title":"Risk of hyperkalemia in patients with type 2 diabetes mellitus prescribed with SGLT2 versus DPP-4 inhibitors","author":"Wu","year":"2023","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107996_b0050","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jacc.2016.10.060","article-title":"Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies","volume":"69","author":"Elze","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107996_b0055","doi-asserted-by":"crossref","first-page":"e871","DOI":"10.1097\/MJT.0000000000000180","article-title":"Trimetazidine in practice: review of the clinical and experimental evidence","volume":"23","author":"Dezsi","year":"2016","journal-title":"Am. J .Ther."},{"issue":"1","key":"10.1016\/j.lungcan.2024.107996_b0060","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","article-title":"Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer","volume":"31","author":"Snaebjornsson","year":"2020","journal-title":"Cell Metab."},{"issue":"5930","key":"10.1016\/j.lungcan.2024.107996_b0065","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.lungcan.2024.107996_b0070","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/s41418-022-01022-y","article-title":"Targeting mitochondrial metabolism for precision medicine in cancer","volume":"29","author":"Sainero-Alcolado","year":"2022","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.lungcan.2024.107996_b0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci"},{"issue":"6","key":"10.1016\/j.lungcan.2024.107996_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101632","article-title":"Trimetazidine alone or in combination with gemcitabine and\/or abraxane decreased cell viability, migration and ATP levels and induced apoptosis of human pancreatic cells","volume":"45","author":"Atli Sekeroglu","year":"2021","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"2","key":"10.1016\/j.lungcan.2024.107996_b0085","doi-asserted-by":"crossref","first-page":"104","DOI":"10.15420\/ecr.2018.15.2","article-title":"Trimetazidine and other metabolic modifiers","volume":"13","author":"Guarini","year":"2018","journal-title":"Eur. Cardiol."},{"issue":"5","key":"10.1016\/j.lungcan.2024.107996_b0090","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10557-022-07340-0","article-title":"The impact of trimetazidine on cardiac fibrosis, inflammation, and function in ischemic cardiomyopathy patients","volume":"37","author":"El-Khodary","year":"2023","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.lungcan.2024.107996_b0095","article-title":"Trimetazidine in heart failure","volume":"11","author":"Shu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lungcan.2024.107996_b0100","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.2147\/DDDT.S463626","article-title":"Trimetazidine alleviates bleomycin-induced pulmonary fibrosis by targeting the long noncoding RNA CBR3-AS1-mediated miRNA-29 and Resistin-Like Molecule alpha 1: Deciphering a Novel Trifecta Role of LncRNA CBR3-AS1\/miRNA-29\/FIZZ1 Axis in Lung Fibrosis","volume":"18","author":"Alzahrani","year":"2024","journal-title":"Drug Des. Devel. Ther."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224005300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224005300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T07:05:54Z","timestamp":1731999954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500224005300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":20,"alternative-id":["S0169500224005300"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107996","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with trimetazidine dihydrochloride and lung cancer survival: Implications on metabolic re-programming","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107996"}}